TIL (Instil Bio, Inc. Common Stock) Stock Analysis - AI Report
Instil Bio, Inc. Common Stock (TIL) is a publicly traded Healthcare sector company. As of May 21, 2026, TIL trades at $8.02 with a market cap of $55.14M and a P/E ratio of -0.76. TIL moved +1.25% today. Year to date, TIL is -34.74%; over the trailing twelve months it is -51.22%. Its 52-week range spans $5.67 to $70.16. Rallies surfaces TIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on TIL?
Rallies AI research for TIL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Laumas Sandeep sold 17.54K (~$404.10K) on Sep 10, 2025.
Laumas Sandeep sold 12.46K (~$297.57K) on Sep 10, 2025.
Vivo Capital IX, LLC bought 300.00K (~$6.00M) on Mar 23, 2021.
TIL Analyst Consensus
TIL analyst coverage data. Average price target: $0.00.
Common questions about TIL
What is the AI research view on TIL?
Rallies AI research for TIL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for TIL?
Rallies AI research for TIL combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is TIL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TIL. It does not provide personalized investment advice.
